Crowdonomics
All companies
SMARTfit logo

SMARTfit

Operating

SMARTfit Inc.

Sports & Recreation · Camarillo, CA · Founded 2013

A neuro-cognitive gym programmed to enhance human performance and brain-body health

Post-money valuation ⓘ
$49.2M
As of Jun 2022 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$7,295,482
Crowd $131K · Private $7.2M · 4 rounds since 2016
Latest share price
$1.12
Reg CF · Common Stock · Feb 2022 offering price

Financials

FY2019–FY2025 · from SEC filings · hover any figure for its source
$902K
−$2.9M
2019
$697K
−$2.4M
2020
$921K
−$2.6M
2021
$939K
$4.8M
2022
$584K
$1.7M
2023
$657K
−$1.6M
2024
$831K
−$2.4M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed
FY2020 reviewed
FY2021 reviewed
FY2022 reviewed
FY2023 reviewed
FY2024 audited
FY2025 audited
Income statement
Revenue
$901,555
$697,363
$921,382
$938,549
$583,849
$657,438
$830,885
Cost of goods sold
$517,336
$224,146
$274,825
$298,343
$187,683
$197,143
$386,396
Gross margin
43%
68%
70%
68%
68%
70%
53%
Net income
-$2,937,322
-$2,449,769
-$2,634,579
$4,783,764
$1,708,943
-$1,622,363
-$2,382,673
Taxes paid
$0
$0
$0
$0
$0
$0
$0
Balance sheet
Cash
$11,290
$8,271
$22,617
$462,179
$128,863
$52,147
$3,513
Accounts receivable
$3,768
$74,588
$9,373
$55,968
$11,851
$0
$42,340
Total assets
$5,485,525
$4,213,131
$2,862,770
$691,480
$1,137,507
$804,590
$643,066
Short-term debt
$1,872,590
$884,355
$1,591,557
$2,202,904
$1,755,401
$3,142,301
$2,280,365
Long-term debt
$236,890
$10,739,680
$12,492,147
$831,711
$4,644,190
$0
$4,021,806
Total liabilities
$2,109,480
$11,624,035
$14,083,704
$3,034,615
$6,399,591
$3,142,301
$6,302,171
Other
Headcount
—
13
13
13
8
10
13

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$49.1M
pre-money
Reg CF · Common · Feb 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$1.12$0.56$0.55
Aug 2016Feb 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · Aug 2021 (-45%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Cap table

Share counts as of Sep 25, 2026
Series A Preferred Stock · 4.05%Common Stock · 96.0%
ClassOutstandingVotes / shareShare of totalVotesDividendLast price
Series A Preferred Stockpreferred4,970none4.05%0%10% cumulative$1.12Feb 2022
Common Stock117,732—96.0%100.0%——
Total122,702100%100%

Principal holders% as the filing states it, Sep 25, 2026

  • Catherine Lamberti9,920,000 Class A Common Stock28.2%of Class A

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Raised $1.6MInvestors 10
Raised $130.6K / $1.1MInvestors 50Post-money $49.2M
Raised $1.2MInvestors 12
Raised $4.3MInvestors 59

Team

19 people
Catherine LambertiFounder
CEO, Founder and Board Chair

Founder and current CEO. Past experiences include SPAR Foodliners (CFO), founder and inventor – Solutions Plus (AUS), SuperSprings Inc. (US), Sportwall Intl Inc., Exercise Technology Inc., Multisensory Technologies Inc., SMARTfit Inc., which have generated combined sales of $100M+.

James ManleyFounder
CTO and Board Member

Jim is the co-founder, major shareholder, and board advisor and is the mastermind behind the engineering platform technology. Past experience includes PALCO Labs, Secosys, Valley Center, 3S, Respironics, Span Instruments, CDI, Liston Scientific, MTI

Tom WestFounder
VP Sales and Marketing

Tom is a co-founder and major shareholder with over 20 years selling the value of interactive technologies into a variety of US and international markets. Past experience includes interactive Fitness Holdings, Exercise Technology, and Head Racquet Sports.

Cathi LambertiFounder
Chief Executive Officer, Chairperson of the board of directors, and founder of SMARTfit
Frauke Wittmer-Grant
Interim CFO, Board Member and Board Secretary

Frauke has been working with the original SMARTfit team for the past 20 years in business development, finance and as corporate secretary. Past experience Amber Engineering, Raytheon, Sportwall Intl Inc, ETI, MTI, MTech Imaging USA, Miltrade Pte Ltd., Aerial Alchemy. She holds a MBA and Masters in Finance

Ryan Glatt
Director of Programming

Ryan is a personal trainer and brain-health coach with over a decade of experience. He currently practices brain-based strategies for cognitive enhancement. Ryan has released the Brain Health Trainer course, which is the first comprehensive course to be released on the topic of brain health and exercise

Beth Fisher, PhD, PT, FAPTA
Scientific Advisor

Professor of Clinical Physical Therapy Director, Neuroplasticity and Imaging Laboratory Division of Biokinesiology and Physical Therapy at USC

Charles Y. Liu, PhD, MD
Scientific Advisor

Professor, Neurosurgery, Neurology, and Biomedical Engineering USC Director, USC Neurorestoration Center Associate Chief Medical Officer and of Neurosurgery at Rancho de Los Amigos

Dr. Rob Winningham
Clinical and Program Development

Dr. Winningham is a Provost and VP for Academic Affairs at Western Oregon University. His main focus is on Cognitive Psychology and Applied Memory Issues in Older Adults.

Show 10 more people
Fabio Macciardi, MD, PhD
Scientific Advisor

UC Irvine Professor, Laboratory of Molecular Psychiatry, Psychiatry & Human Behavior School of Medicine

Martin Teicher, MD, PhD
Scientific Advisor

Director, Developmental Biopsychiatry Research Program Harvard Medical School, Associate Professor of Psychiatry

Mike Studer, PT, MHS, NCS, CEEAA, CWT, CSST, FAPTA
Clinical and Program Development

Mike has been board-certified as a Clinical Specialist in Neurologic Physical Therapy since 1995. He also holds the distinction of being the only PT in the US to be recognized with the national award for clinical excellence in two different categories, neurology and geriatrics. Mike is considered a Key Opinion Leader and is a sought-after speaker including appearances on TED talk.

Phillip D. Tomporowski, PhD
Scientific Advisor

University of Georgia, ACSM Fellow, Author, Experimental Psychologist

Yi Jin, MD
Scientific Advisor

Department of Psychiatry and Human Behavior, California College of Medicine, University of California, Irvine

Greg Blanchard
Director

Founder and CEO of Dynamic Direct, which provides design services to Fortune 500 companies, including Disney, Hilton, NY Yankees, Wolfgang Puck, and many more. Greg Blanchard was one of SMARTfit's original shareholders.

Gregg Fienberg
Director

One SMARTfit’s early investors and one of HBO’s top executive producers since 2000, Gregg Fienberg has been a Movie/TV producer for the past 35 years, running multiple shows of over $100 million each, including marketing, web design, etc. These productions are extremely complex, chaotic and dynamic in their execution, so Mr. Fienberg brings to SMARTfit his extensive experience managing large projects from their inception to completion in the most efficient way possible.

Jason Polete
Director

Chief Executive Officer of MDAmerica Group, Jason Polete has spent nearly three decades in healthcare technology and administration, with extensive experience in the rehabilitative/rehabilitation service industries, involving operational, administrative and revenue cycle aspects of the business.

Michael Hayes
Director

Michael has his own company and has been a consultant/coach/counselor for the past 43 years. He has extensive experience developing small businesses into successful enterprises through consulting, networking and advising on marketing and business topics. For the past 20 years he has been on the board of directors of a very successful manufacturing company.

Diego Jacobson
Board member

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 5 of 5 annual reports (FY2021–FY2025)

59 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-ARSep 25, 20260001715110-26-000005
    EDGAR
  • Form C-ARApr 9, 20250001665160-25-000536
    EDGAR
  • Form C-ARApr 25, 20240001665160-24-000487
    EDGAR
  • Form C-AR/AMay 2, 20230001665160-23-001146
    EDGAR
  • Form C-AR/AApr 28, 20230001665160-23-000961
    EDGAR
  • Form C-ARApr 21, 20230001665160-23-000691
    EDGAR
  • Form C-USep 29, 20220001665160-22-002532
    EDGAR
  • Form C-UJun 30, 20220001665160-22-001951
    EDGAR
Source: ManualCIK 0001715110CAShare price $0.55

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.